FDA Adverse Event Malfunction Summary report: N

SKELETAL DYNAMICS

MDR report key: 10721987 · Received October 22, 2020

Report

Report Number
3006742481-2020-00010
Event Type
Malfunction
Date Received
October 22, 2020
Date of Event
September 22, 2020
Report Date
October 22, 2020
Manufacturer
SKELETAL DYNAMICS
Product Code
OZI
UDI-DI
00841506104904
PMA / PMN Number
K153208
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 1

NO DEVICE PROBLEMS WERE IDENTIFIED. THE INSTRUCTIONS FOR USE FOR THE SYSTEM STATES THE INDICATIONS FOR USE AS: "THE IJS-E SYSTEM IS INTENDED TO PROVIDE TEMPORARY STABILIZATION OF THE ELBOW JOINT AFTER TRAUMA OR CHRONIC ELBOW DISLOCATION. FOR SAFE EFFECTIVE USE OF THE IMPLANT, THE SURGEON MUST BE THOROUGHLY FAMILIAR WITH THE SURGICAL TECHNIQUE FOR THE DEVICE, IMPLANT, AND ASSOCIATED INSTRUMENTS. POTENTIAL IJS-E CONSTRUCT FAILURES SUCH AS STRESS FRACTURES OF THE BONES, LOOSENING OF THE CONSTRUCT, INSTABILITY, DELAYED SOFT TISSUE HEALING, SOFT TISSUE IRRITATION, OR INCOMPLETE HEALING MAY OCCUR AS A RESULT OF NON-COMPLIANCE TO POST-OPERATIVE REHABILITATION, EXCESSIVE ELBOW ACTIVITIES OR CONSTRUCT OVERLOADING." FURTHERMORE, THIS DEVICE CONTRAINDICATIONS STATE: "THE IJS-E SYSTEM SHOULD NOT BE USED IF THE FOLLOWING ARE PRESENT: ACTIVE OR LATENT INFECTION, SEPSIS, INSUFFICIENT QUANTITY OR QUALITY OF BONE (BONE LOSS GREATER THAN 30% OF THE TOTAL ARTICULATION OR INVOLVING AN ENTIRE COLUMN OF THE DISTAL HUMERUS, CORONOID BONE LOSS OF 50% OR MORE" BONE LOSS GREATER THAN 30% OF THE TOTAL ARTICULATION WAS IDENTIFIED IN THE IMAGING PROVIDED VIOLATING THE CONTRAINDICATION LISTED ABOVE. THE PROCEDURE PERFORMED WAS AN INTERPOSITIONAL JOINT ARTHROPLASTY WITH PLACEMENT OF IJS.

Description of Event or Problem · 1

IMPLANT REVISION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1186189 SKELETAL DYNAMICS INTERNAL JOINT STABALIZER OZI SKELETAL DYNAMICS IJS-E Base Plate Assembly 00841506104904

Patients

Seq Age Sex Outcome Treatment
1 68 YR Required Intervention